← Leaderboards
Hua Li
Washington University
$3,159,930
Attributed
$4,335,424
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,335,424 · 4
By mechanism
R01$3,294,238 · 2
R56$673,102 · 1
R21$368,084 · 1
Top collaborators
- Xiaowei Wang3 shared
- Perry Wayne Grigsby2 shared
Most similar at Washington University
Same institution · by research overlap
- Xiaowei Wang$9,035,077
- Jose P. Zevallos$1,638,729
- Mary M. Zutter$12,598,946
- Sanjay Jain$27,367,157
- Quing Zhu$6,933,345
Others in their field
Other Emerging Leaders on “Heterogeneity”
- Chanza Baytop · Westat, Inc.$271,217,917
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Christopher Barnaby Nelson · University Of Melbourne$27,954,628
- Kathleen Maletic Neuzil · Emory University$26,258,144
- George Robert Painter · University Of Alabama At Birmingham$25,957,440
- Jennifer Marie Suga · Kaiser Foundation Research Institute$21,704,579
Research focus
HeterogeneityImageClinical Decision-MakingCohortTumorPatient StratificationTreatment OutcomeUncertaintyResponsePrognosticFutureClinical ApplicationBiological MarkersImaging BiomarkerCancer BiomarkersPrognostic MarkerClinically RelevantClinical TreatmentPrognostic ValuePlayPredictive ModelingCancer TherapyDecision MakingCancer Patient
Grant awards (11)
Combined Imaging and RNA Analyses to Develop Cervical Cancer Biomarkers$648,501
R01 · FY2025 · CA · contact PI
Combined Imaging and RNA Analyses to Develop Cervical Cancer Biomarkers$661,302
R01 · FY2024 · CA · contact PI
Multimodal Biomarkers For Oropharyngeal Cancer$369,462
R01 · FY2024 · CA · contact PI
Combined Imaging and RNA Analyses to Predict Head and Neck Cancer Recurrence$673,102
R56 · FY2023 · DE · contact PI
Multimodal Biomarkers For Oropharyngeal Cancer$382,285
R01 · FY2023 · CA · contact PI
Multimodal Biomarkers For Oropharyngeal Cancer$385,655
R01 · FY2021 · CA · contact PI
Multimodal Biomarkers For Oropharyngeal Cancer$10,793
R01 · FY2021 · CA · contact PI
Multimodal Biomarkers For Oropharyngeal Cancer$416,519
R01 · FY2020 · CA · contact PI
Multimodal Biomarkers For Oropharyngeal Cancer$419,721
R01 · FY2019 · CA · contact PI
RADIOMICS-BASED PROGNOSTIC MODEL OF CERVICAL CANCER HABITATS$165,483
R21 · FY2019 · CA
RADIOMICS-BASED PROGNOSTIC MODEL OF CERVICAL CANCER HABITATS$202,601
R21 · FY2018 · CA · contact PI